However, the prevalence of MuSK‐positive patients among AchR‐negative patients was 17.6% and thereby comparable to the prevalence of other European MG cohorts (Kostera‐Pruszczyk et al., 2008; Niks, Kuks, & Verschuuren, 2007). The gene discussed is MUSK; the disease is myasthenia gravis.